• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sidoti Events, LLC's Virtual June Small-Cap Conference

    6/11/24 10:50:00 AM ET
    $AGI
    $ALUR
    $ATOS
    $BRC
    Precious Metals
    Basic Materials
    Medical/Dental Instruments
    Health Care
    Get the next $AGI alert in real time by email

    NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.

    Presentation Schedule

    *All Times EDT

    Wednesday, June 12, 2024 (Day 1)

    8:30-9:00

    *****

    *****

    InfuSystem Holdings Inc. (INFU)

    *****

    9:15-9:45

    *****

    ECD Automotive (ECDA)

    Lifeward [ReWalk Robotics] (LFWD)

    *****

    10:00-10:30

    Unisys Corporation (UIS)

    *****

    Myomo, Inc (MYO)

    Drilling Tools International Corp. (DTI)

    10:45-11:15

    American Software (AMSWA)

    USANA Health Sciences (USNA)

    Assertio Holdings, Inc. (ASRT)

    Information Services Group ["ISG"] (III)

    11:30-12:00

    Vishay Precision Group (VPG)

    Global Industrial Company (GIC)

    Zomedica Corp. (ZOM)

    Charles River Associates (CRAI)

    12:15-12:45

    Quad/Graphics Inc (QUAD)

    *****

    RadNet, Inc. (RDNT)

    *****

    1:00-1:30

    *****

    Rayonier Advanced Materials ["RYAM"] (RYAM)

    Superior Group of Companies (SGC)

    Portman Ridge Finance Corp (PTMN)

    1:45-2:15

    *****

    Electromed (ELMD)

    Senseonics Holdings, Inc. (SENS)

    BioLargo, Inc. (BLGO)

    2:30-3:00

    A10 Networks, Inc. (ATEN)

    Granite Ridge Resources, Inc. (GRNT)

    Theravance Biopharma (TBPH)

    ARC Document Solutions (ARC)

    3:15-3:45

    GlucoTrack Inc. (GCTK)

    Canoo (GOEV)

    Bitcoin Depot (BTM)

    Topaz Energy Corp (TSX:TPZ)

    4:00-4:30

    Intelligent Bio Solutions (INBS)

    Brilliant Earth Group, Inc. (BRLT)

    Oportun Financial Corp. (OPRT)

    TrueBlue (TBI)

    1x1s Only

    (12th)

    GATX Corporation (GATX)

    Hillenbrand (HI)

    MYR Group Inc. (MYRG)

    Pitney Bowes (PBI)

    Primoris Services Corporation (PRIM)

    Sonendo (SONX)

    Titan International, Inc. (TWI)

    *****

    *All Times EDT

    Thursday, June 13, 2024 (Day 2)

    8:30-9:00

    GDEV Inc. (GDEV)

    *****

    Meihua Intl. Medical Technologies Co. (MHUA)

    *****

    9:15-9:45

    Commercial Vehicle Group (CVGI)

    Atossa Therapeutics (ATOS)

    Citius Pharmaceuticals, Inc. (CTXR)

    *****

    10:00-10:30

    Paysign, Inc. (PAYS)

    Graham Corporation (GHM)

    Allurion (ALUR)

    Mobile Infrastructure (BEEP)

    10:45-11:15

    *****

    Genco Shipping & Trading Ltd (GNK)

    VAREX IMAGING (VREX)

    Nature's Sunshine (NATR)

    11:30-12:00

    *****

    Brady Corporation (BRC)

    BioHarvest Sciences Inc. (CNVCD)

    Hovnanian Enterprises Inc (HOV)

    12:15-12:45

    *****

    Great Lakes Dredge & Dock Corp. (GLDD)

    *****

    CES Energy Solutions (CEU-TSX)

    1:00-1:30

    Sonim Technologies Inc. (SONM)

    Amerigo Resources (ARREF)

    *****

    The Real Brokerage Inc (REAX)

    1:45-2:15

    *****

    NN Inc. (NNBR)

    *****

    Consumer Portfolio Services (CPSS)

    2:30-3:00

    *****

    Alamos Gold Inc. (AGI)

    GoHealth (GOCO)

    Resources Connection, Inc. (RGP)

    1x1s Only

    (13th)

    Belden Inc. (BDC)

    CSW Industrials (CSWI)

    Federal Signal Corporation (FSS)

    HNI Corporation (HNI)

    OneSpan Inc. (OSPN)

    Plexus Corp. (PLXS)

    Sonendo (SONX)

    *****

    About Sidoti Events, LLC ("Events") and Sidoti & Company, LLC ("Sidoti")
    In 2023, Sidoti & Company, LLC (www.sidoti.com) formed an affiliate company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the 25 years of experience Sidoti has as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises approximately 150 equities of which greater than 60 percent participate in the firm's rapidly growing Company Sponsored Research ("CSR") program. In 2024, Sidoti established Lighthouse Equity Research as an extension of its CSR program to meet the specific needs of companies not valued using traditional metrics or that face challenges obtaining coverage due to political risks or other factors. Events is a leading provider of corporate access through the eight investor conferences it hosts each year. By virtue of its direct ties to Sidoti, Event's benefits from Sidoti's small- and microcap-focused nationwide sales force, which has connections with 2,500 institutional relationships in North America. This enables Events to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.

    SOURCE: Sidoti Events, LLC



    View the original press release on accesswire.com

    Get the next $AGI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGI
    $ALUR
    $ATOS
    $BRC

    CompanyDatePrice TargetRatingAnalyst
    Graham Corporation
    $GHM
    3/18/2026$100.00Outperform
    Oppenheimer
    Genco Shipping & Trading Limited
    $GNK
    2/19/2026Buy → Neutral
    Alliance Global Partners
    Great Lakes Dredge & Dock Corporation
    $GLDD
    2/12/2026Outperform → Market Perform
    Noble Capital Markets
    Graham Corporation
    $GHM
    2/10/2026Market Perform → Outperform
    Northland Capital
    Graham Corporation
    $GHM
    1/27/2026$80.00Outperform → Market Perform
    Northland Capital
    Great Lakes Dredge & Dock Corporation
    $GLDD
    1/22/2026$20.00Overweight
    Analyst
    Alamos Gold Inc.
    $AGI
    11/28/2025Buy
    Desjardins
    GoHealth Inc.
    $GOCO
    11/19/2025Outperform → Mkt Perform
    William Blair
    More analyst ratings

    $AGI
    $ALUR
    $ATOS
    $BRC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oppenheimer initiated coverage on Graham with a new price target

    Oppenheimer initiated coverage of Graham with a rating of Outperform and set a new price target of $100.00

    3/18/26 8:23:26 AM ET
    $GHM
    Industrial Machinery/Components
    Industrials

    Genco Shipping & Trading downgraded by Alliance Global Partners

    Alliance Global Partners downgraded Genco Shipping & Trading from Buy to Neutral

    2/19/26 7:39:00 AM ET
    $GNK
    Marine Transportation
    Consumer Discretionary

    Great Lakes Dredge & Dock downgraded by Noble Capital Markets

    Noble Capital Markets downgraded Great Lakes Dredge & Dock from Outperform to Market Perform

    2/12/26 8:58:11 AM ET
    $GLDD
    Military/Government/Technical
    Industrials

    $AGI
    $ALUR
    $ATOS
    $BRC
    SEC Filings

    View All

    SEC Form DEFA14A filed by Genco Shipping & Trading Limited

    DEFA14A - GENCO SHIPPING & TRADING LTD (0001326200) (Filer)

    3/19/26 8:11:50 AM ET
    $GNK
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 14D9/A filed by Great Lakes Dredge & Dock Corporation

    SC 14D9/A - Great Lakes Dredge & Dock CORP (0001372020) (Subject)

    3/18/26 4:21:42 PM ET
    $GLDD
    Military/Government/Technical
    Industrials

    Great Lakes Dredge & Dock Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Great Lakes Dredge & Dock CORP (0001372020) (Filer)

    3/18/26 9:23:39 AM ET
    $GLDD
    Military/Government/Technical
    Industrials

    $AGI
    $ALUR
    $ATOS
    $BRC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology

    VANCOUVER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary — Big money is moving back into biotech. Institutional investors have been writing some of the largest checks in years, with major financing rounds already closing in the first months of 2026[1], a sign that capital is rotating toward clinical-stage companies with validated science. That capital is not spreading evenly: it is concentrating on precision medicine, where the global oncology precision medicine market is projected to reach $303 billion by 2035[2], growing at approximately 9% annually as targeted cancer treatments move from promising idea to standard care. The five companies in thi

    3/19/26 11:00:00 AM ET
    $ATOS
    $ONCY
    $SNSE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives

    Kathy Puyana Theall, M.D. and Adebola Giwa, M.D. bring deep expertise across oncology, rare diseases, and global clinical development to support advancement of Atossa's pipelineSEATTLE, March 19, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other rare diseases, today announces the engagement of Kathy Puyana Theall, M.D., as Medical Director - Breast Oncology, and Adebola Giwa, M.D., as Medical Director - Rare Diseases.  The addition of these two highly experienced physicians and clinical leaders meaningfully strengthens Atossa's ability to execute on its (Z)-endo

    3/19/26 8:00:00 AM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Genco Shipping & Trading Rejects Revised, Non-Binding Indicative Proposal from Diana Shipping Inc.

    Proposal Substantially Undervalues Genco, Fails to Provide an Appropriate Premium and Presents Execution Risks "Fire Sale" of 16 Genco Vessels to a Competitor Highlights Diana's Undervalued Proposal Board Remains Open to Engaging with Diana on an Offer That Recognizes Genco's Full Value for All Shareholders NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Genco Shipping & Trading Limited (NYSE:GNK) ("Genco" or the "Company"), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today announced that its Board of Directors unanimously rejected Diana Shipping Inc.'s revised, non-binding indicative proposal to acquire all of the outstanding shar

    3/19/26 8:00:00 AM ET
    $GNK
    Marine Transportation
    Consumer Discretionary

    $AGI
    $ALUR
    $ATOS
    $BRC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Kelsey Todd P.

    4 - PLEXUS CORP (0000785786) (Issuer)

    3/19/26 4:16:32 PM ET
    $PLXS
    Electrical Products
    Technology

    SEC Form 4 filed by Great Lakes Dredge & Dock Corporation

    4 - Great Lakes Dredge & Dock CORP (0001372020) (Issuer)

    3/18/26 5:22:24 PM ET
    $GLDD
    Military/Government/Technical
    Industrials

    SEC Form 4 filed by Petterson Lasse

    4 - Great Lakes Dredge & Dock CORP (0001372020) (Issuer)

    3/18/26 5:10:38 PM ET
    $GLDD
    Military/Government/Technical
    Industrials

    $AGI
    $ALUR
    $ATOS
    $BRC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gregorio Mauro bought $58,812 worth of shares (1,200 units at $49.01) (SEC Form 4)

    4 - GRAHAM CORP (0000716314) (Issuer)

    9/15/25 4:26:30 PM ET
    $GHM
    Industrial Machinery/Components
    Industrials

    President & CEO Quay Steven C bought $9,887 worth of shares (11,239 units at $0.88), increasing direct ownership by 423% to 13,898 units (SEC Form 4)

    4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)

    5/22/25 6:27:25 PM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Gaur Shantanu bought $24,484 worth of shares (8,000 units at $3.06), increasing direct ownership by 100% to 16,000 units (SEC Form 4)

    4 - ALLURION TECHNOLOGIES, INC. (0001964979) (Issuer)

    5/21/25 4:15:08 PM ET
    $ALUR
    Medical/Dental Instruments
    Health Care

    $AGI
    $ALUR
    $ATOS
    $BRC
    Leadership Updates

    Live Leadership Updates

    View All

    Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives

    Kathy Puyana Theall, M.D. and Adebola Giwa, M.D. bring deep expertise across oncology, rare diseases, and global clinical development to support advancement of Atossa's pipelineSEATTLE, March 19, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other rare diseases, today announces the engagement of Kathy Puyana Theall, M.D., as Medical Director - Breast Oncology, and Adebola Giwa, M.D., as Medical Director - Rare Diseases.  The addition of these two highly experienced physicians and clinical leaders meaningfully strengthens Atossa's ability to execute on its (Z)-endo

    3/19/26 8:00:00 AM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Graham Corporation Announces Appointment of William Zmyndak as Deputy General Manager of Graham Manufacturing

    Alan Smith, Vice President and General Manager of Graham Manufacturing to retire in April 2026 and will serve in an advisory role moving forward William Zmyndak is expected to assume the role of Vice President and General Manager of Graham Manufacturing upon Mr. Smith's retirement Additionally, the Company announces the appointments of Keith Oufnac as Chief Information Officer and Rachel Jaakkola as Chief Human Resources Officer Graham Corporation (NYSE:GHM) ("GHM" or the "Company"), a global leader in the design and manufacture of mission critical fluid, power, heat transfer vacuum, and advanced mixing technologies for the Defense, Energy & Process and Space industries, today announc

    2/17/26 8:00:00 AM ET
    $GHM
    Industrial Machinery/Components
    Industrials

    Atossa Therapeutics Issues Letter to Shareholders Highlighting 2025 Accomplishments and 2026 Outlook

    SEATTLE, Feb. 11, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet need, today issued a letter to Shareholders from Steven Quay, M.D., Ph.D., Atossa Therapeutics President and Chief Executive Officer, providing an update on the Company's clinical programs and recent events. The full text of the letter follows: To our valued shareholders, In looking back on 2025, Atossa made meaningful progress advancing proprietary oral (Z)-en

    2/11/26 8:30:00 AM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGI
    $ALUR
    $ATOS
    $BRC
    Financials

    Live finance-specific insights

    View All

    Genco Shipping & Trading Rejects Revised, Non-Binding Indicative Proposal from Diana Shipping Inc.

    Proposal Substantially Undervalues Genco, Fails to Provide an Appropriate Premium and Presents Execution Risks "Fire Sale" of 16 Genco Vessels to a Competitor Highlights Diana's Undervalued Proposal Board Remains Open to Engaging with Diana on an Offer That Recognizes Genco's Full Value for All Shareholders NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Genco Shipping & Trading Limited (NYSE:GNK) ("Genco" or the "Company"), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today announced that its Board of Directors unanimously rejected Diana Shipping Inc.'s revised, non-binding indicative proposal to acquire all of the outstanding shar

    3/19/26 8:00:00 AM ET
    $GNK
    Marine Transportation
    Consumer Discretionary

    Star Bulk to Acquire 16 Vessels from Diana Shipping Inc. Conditional Upon the Success of Its Offer to Acquire Genco Shipping & Trading Ltd

    ATHENS, Greece, March 06, 2026 (GLOBE NEWSWIRE) -- Star Bulk Carriers Corp. (the "Company" or "Star Bulk") (NASDAQ:SBLK), today announced it has entered into a conditional Sale and Purchase Agreement (the "SPA") to acquire sixteen vessels from Diana Shipping Inc. (("Diana", NYSE:DSX), subject to Diana successfully acquiring all issued and outstanding shares of Genco Shipping & Trading Ltd. (("Genco", NYSE:GNK), not already owned by Diana. The aggregate purchase price for the sixteen-vessel acquisition is $470.5 million in cash ("Purchase Price"). The SPA is subject to (i) an agreement being entered between Diana and Genco and successfully being consummated and (ii) customary conditions to

    3/6/26 9:29:37 AM ET
    $DSX
    $GNK
    $SBLK
    Marine Transportation
    Consumer Discretionary

    Diana Shipping Inc. Increases Offer to Acquire Genco Shipping & Trading in Partnership With Star Bulk Carriers

    Revised Offer of $23.50 Per Share Represents 31% Premium Over Undisturbed Closing Price Prior to Initial Offer Receives Fully Underwritten Commitment for $1.433 Billion in Financing Arranged by DNB Carnegie and Nordea, and Including Other Leading International Banks Star Bulk Enters into Definitive Agreement with Diana to Acquire 16 Genco Vessels for $470.5 Million Calls Upon Genco Board to Immediately Engage in Good Faith Negotiations to Reach Definitive Agreement ATHENS, Greece, March 06, 2026 (GLOBE NEWSWIRE) -- Diana Shipping Inc. (NYSE:DSX) ("Diana" or the "Company"), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, that owns ap

    3/6/26 9:27:00 AM ET
    $DSX
    $GNK
    $SBLK
    Marine Transportation
    Consumer Discretionary

    $AGI
    $ALUR
    $ATOS
    $BRC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Citius Pharmaceuticals Inc.

    SC 13D/A - Citius Pharmaceuticals, Inc. (0001506251) (Subject)

    11/27/24 4:05:31 PM ET
    $CTXR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Meihua International Medical Technologies Co. Ltd.

    SC 13G - Meihua International Medical Technologies Co., Ltd. (0001835615) (Subject)

    11/14/24 6:08:55 PM ET
    $MHUA
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Allurion Technologies Inc.

    SC 13G/A - ALLURION TECHNOLOGIES, INC. (0001964979) (Subject)

    11/14/24 4:43:43 PM ET
    $ALUR
    Medical/Dental Instruments
    Health Care